POPULARITY
This episode is part two of the great emerging viruses talk with Dr. Ryan Relich and Benjamin Pinsky. They talk over diagnostic tests for viruses, challenges with test development, and they share their thoughts on viruses and outbreaks. Link to the National Academies Arbovirus workshop: https://www.nationalacademies.org/our-work/mitigating-arboviral-threats-and-strengthening-public-health-preparedness-a-workshopLink to the Pan American Society for Clinical Virology: https://www.pascv.org/default.aspx
Cassandra Extavour is a Professor of developmental and evolutionary biology at Harvard University, and she is an Investigator at the prestigious Howard Hughes Medical Institute. Cassandra's pioneering research focuses on how germ cells – those immortal cells that form the next generation – are specified in different animals. Cassandra is a champion for diversity and inclusivity, helping to found the Pan-American Society of Evolutionary Developmental Biology. Cassandra has a second, part-time job as a professional soprano, singing opera and Baroque music with professional ensembles around the world, and we talked with her about how creativity in science and music is similar. Our conversation with Cassandra led us to discuss how reading broadly across fields and generations forms the substrate for new ideas, and how speaking the “languages” of different fields can stimulate ideas. For more information on Night Science, visit https://www.biomedcentral.com/collections/night-science .
We are just back from the Molecular Virology Workshop in West Palm Beach. This is a terrific meeting that is organized by the Pan-American Society for Clinical Virology or PASCV. The workshop immediately precedes the Clinical Virology Symposium that ASM organizes and many of us like to attend both. Today we'll be talking about some of the high points of the Molecular Virology Workshop, with two members of the organizing committee from PASCV. Guests: Dr. Erin Graf, Director, Clinical Microbiology at Mayo Clinic in Phoenix Arizona. Dr. Stephanie Mitchell, Director of Medical Affairs at Cepheid. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Links: On-demand sessions from PASCV https://www.pascv.org/page/MVW Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter via @JClinMicro
"The Most Important Thing is To Have Passion" - Dr. J. Roberto Trujillo, M.D Hi, Ditch Digger CEO listeners. We did something a little different with Dr. Roberto's episode. This guy is so amazing and has so much to talk about. We had to create two parts. It was great timing for us to create two parts because something has happened in the last week that I'm super excited about. Dr. Roberto has scheduled my son Nik and I to go to his research center in Bangalore, India to be treated. Nik for cerebral palsy and me for epilepsy. We will be going for 28 days of treatment. Both of our cases are on the mild side of the spectrum. We know we have challenges to overcome and there's no proven cure for either of our diseases. We will also be going to get a chance to understand the technology and the protocol in case my wife Cheryl needs to go to Dr. Roberto's clinic for treatment of her brain cancer and other presumed incurable disease. So strap on your seat belts as we enjoy one of the leading minds in the world of medicine today, Dr. Roberto Trujillo, with his slogan to cure the incurable. Enjoy! Dr. J. Roberto Trujillo, M.D., Sc.D. is the Chairman and CEO of TruCytonics Institute & NeuroCytonix, Inc., at the Montgomery Biotechnology campus of Johns Hopkins University. His current focus is on translation research of neural tissue engineering (quantum magnetic resonance) for the treatment of neurodegenerative diseases, including Alzheimer’s disease, stroke and Parkinson’s disease. He is a member of the medical advisory board at Fisher Wallace Laboratories, LLC. As a pioneer in the field of neurovirology at Harvard, Dr. Trujillo founded the Pan-American Society of NeuroVirology in 2000. He is the co-inventor of CERCA, a U.S. patented photodynamic therapeutic medical device for the prevention of cervical cancer. Dr. Trujillo is a leader of medical sciences of the Americas, and he has received numerous awards, professional titles, and honorary doctor degrees. Following an internship in medicine at Baylor College of Medicine, he completed a two-year clinical neurological and neurosurgical fellowship at Texas Medical Center. After receiving a training award from NIH, Dr. Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University. 01:30- Brain dogma: "I never gave up because I wanted to serve people" 08:30- Dreaming big gets us to the moon 10:38- Success with NeuroCytonix and looking forward 14:48- Where this progress will go in the next 5-10 years 17:00- $280 Billion spent on this research and why it costs so much 20:27- The beauty of being an American 23:55- The source of Roberto's focus 25:52- Back pain cure takes time 29:10- How Roberto's technology helps a patient with epilepsy 34:50- AMAZING brain cancer trials and improvements without side effects 38:55- FDA approval status 40:06- The exact process of Roberto's technology 45:05- About Roberto's family 50:30- Doctors need to learn business Connect with Gary Rabine and DDCEO: Visit DDCEO on iTunes Visit our Website Like DDCEO on Facebook Follow DDCEO on Twitter Follow DDCEO on Instagram
"The Most Important Thing is To Have Passion" - Dr. J. Roberto Trujillo, M.D Dr. J. Roberto Trujillo, M.D., Sc.D. is the Chairman and CEO of TruCytonics Institute & NeuroCytonix, Inc., at the Montgomery Biotechnology campus of Johns Hopkins University. His current focus is on translation research of neural tissue engineering (quantum magnetic resonance) for the treatment of neurodegenerative diseases, including Alzheimer’s disease, stroke and Parkinson’s disease. He is a member of the medical advisory board at Fisher Wallace Laboratories, LLC. As a pioneer in the field of neurovirology at Harvard, Dr. Trujillo founded the Pan-American Society of NeuroVirology in 2000. He is the co-inventor of CERCA, a U.S. patented photodynamic therapeutic medical device for the prevention of cervical cancer. Dr. Trujillo is a leader of medical sciences of the Americas, and he has received numerous awards, professional titles, and honorary doctor degrees. Following an internship in medicine at Baylor College of Medicine, he completed a two-year clinical neurological and neurosurgical fellowship at Texas Medical Center. After receiving a training award from NIH, Dr. Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University. 02:24- Story of how Gary and Dr. Roberto Trujillo met 05:30- Roberto's story and upbringing 11:25- Started rotation at age 18 12:00- Difference between US and Mexican medical school 16:54- Challenges are opportunities to grow 19:50- Passion is to study the brain 23:25- AIDS virus causes so much damage to the brain 23:55- Becoming the first molecular neuro-virologist at Harvard 25:52- The importance of passion 28:30- 3 keys to success 29:52- Advantages in America 32:50- If you have an idea you can pursue it, unreal medicine 37:35- All about the NeuroCytonix company 39:40- What clinics look like in America vs India 42:25- Turning brain dogma upside down Tune in for part 2 next week! Connect with Gary Rabine and DDCEO: Visit DDCEO on iTunes Visit our Website Like DDCEO on Facebook Follow DDCEO on Twitter Follow DDCEO on Instagram
Brianne and Vincent tackle two studies that utilize infectious viruses to examine zoonotic potential of Bombali virus, a new ebolavirus from an insectivorous species in Sierra Leone, and a human mumps-like virus from an African flying fox in DRC. Hosts: Vincent Racaniello and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pan American Society for Clinical Virology San Diego and Houston Regional Meetings It's not SARS 2.0 (TWiV 364) Bats out of hell (TWiV 183) Bombali virus, a new Ebolavirus (Nat Micro) Asymptomatic Ebolavirus infections (virology blog) Bat-borne mumps virus (Cell Rep) Image credit Letters read on TWiV 517 Timestamps by Jolene. Thanks! Weekly Science Picks Brianne - Ed Yong on AFM Vincent - Goggles Optional podcast (especially #243) Intro music is by Ronald Jenkees. Send your virology questions and comments to twiv@microbe.tv
Lonya and Jeremy take the TWiV team beTWIXt primate immunodeficiency virus proteins Vpx and Vpr and how they counteract transcriptional repression of proviruses by the HUSH complex. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler, and Brianne Barker Guests: Leonid Yorkovetskiy and Jeremy Luban Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pan American Society for Clinical Virology San Diego and Houston Regional Meetings Vpr and Vpx counter HUSH (Nat Micro) Vpr and Vpx counter HUSH (bioRxiv version) Schematic of HUSH complex (Lehner lab) Olive colobus monkey sound credit Image credit: William (Ted) Diehl Letters read on TWiV 516 Timestamps by Jolene. Thanks! Weekly Science Picks Brianne - The Chimp and the River by David Quammen Rich- James Cook’s First Voyage Journal (20 sec Google Earth summary) Kathy- High resolution Antarctica map NYTimes 46MB Maps (more info and 43 tb maps) Dickson- Jellyfish Jeremy - Pictorial Guide to Living Primates; All The World's PrimatesLonya- Chougui et al. HIV-2/SIV Vpx counters HUSH Vincent - Research!America Intro music is by Ronald Jenkees. Send your virology questions and comments to twiv@microbe.tv